Table 2

Demographic and clinical characteristics of study participants

CharacteristicGroup; mean ± SD (range)*
MDD, n = 50Control, n = 33
Age, yr43.78 ± 1439.33 ± 12
Sex, no. male:female23:2714:19
Adjusted education, yr15.78 ± 2.7016.94 ± 2.30
Handedness, dextral:nondextral37:1228:4
No. of ECT index sessions§9.96 ± 4.05 (1–22)
Lead placement, no. of RUL:mixed:bilateral§34:13:1
Diagnosis, unipolar:bipolar43:7
No. of responders:remitters19:13
Age at onset, yr27.75 ± 12.23
Duration of current episode, yr1.81 ± 2.82
Lifetime duration of illness, yr17.78 ± 13.31
Time pointT1, n = 50T2, n = 42T3, n = 33C1, n = 33C2, n = 31
HAMD-1724.91 (5.93)**20.20 (6.23)††12.46(8.04)‡‡
QIDS-SR20.53 (4.06)**16.78(4.87)††10.27(5.80)‡‡
MADRS39.04 (9.23)**32.66 (8.68)††16.42(11.47)‡‡
  • C1 = control baseline; C2 = control follow-up; ECT = electroconvulsive therapy; HAMD-17 = Hamilton Rating Scale for Depression; MADRS = Montgomery–Åsberg Depression Rating Scale; QIDS-SR = Quick Inventory of Depressive Symptomatology – Self-Report; RUL = right unilateral lead placement; SD = standard deviation; T1 = patient baseline; T2 = after the second session of ECT; T3 = after the ECT index series.

  • * Unless indicated otherwise.

  • Data missing for 1 patient.

  • Estimated using the modified Edinburgh Handedness Inventory, where a laterality quotient of < 0.7 defined nondextrals. Data missing for 1 control.

  • § Data missing for 2 patients.

  • Response defined as > 50% improvement in HAMD-17 scores over the course of treatment. Remitters defined as patients with HAMD-17 scores < 7 at the end of ECT.

  • ** Significant effect between T1 and T2.

  • †† Significant effect between T2 and T3.

  • ‡‡ Significant effect between T1 and T3.